Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Equipment
  3. usa massachusetts
  4. disease development
Show results for
Products
Services
Applications

Companies


Refine by
Locations
Back to All Locations

  • USA
  • Massachusetts
Brands

  • alexio
  • cambridge interventional
  • finch
  • intellia
  • ysopia
Applications

  • Microbiome Therapeutics for Clinical Trials

Disease Development Equipment Supplied In Usa Massachusetts

8 equipment items found
In MassachusettsAvailable In MassachusettsNear Massachusetts

The PhenoCycler Solution

The PhenoCycler Solution

Manufactured by:Akoya Biosciences   based inMarlborough, MASSACHUSETTS (USA)
Characterizing the complexities of the tissue microenvironment is a critical step towards understanding molecular and cellular mechanisms associated with disease development, differentiation, and response. The PhenoCycler®-Fusion allows spatial phenotyping of millions of cells at unprecedented scale and speed. Mapping millions of cells and their ...
CONTACT SUPPLIER

Alexio - Model RARE ANSWERS - System of Innovative and Sustainable Diagnostic Tools

Alexio - Model RARE ANSWERS - System of Innovative and Sustainable Diagnostic Tools

by:Alexion Pharmaceuticals, Inc.   based inBoston, MASSACHUSETTS (USA)
People with rare diseases often wait years to receive a proper diagnosis and many never receive one at all. RARE ANSWERS™ is a system of innovative and sustainable tools designed to help shorten the diagnostic journey and time to initiating treatment of children with a rare disease. Developed in collaboration with leading children’s ...
CONTACT SUPPLIER

Cambridge Interventional - CRF Radiofrequency Ablation System for Tissue Coagulation

Cambridge Interventional - CRF Radiofrequency Ablation System for Tissue Coagulation

Manufactured by:Cambridge Interventional, LLC   based inBurlington, MASSACHUSETTS (USA)
With FDA approval and CE marking, the system is recognized for its robust performance in minimally invasive thermal ablation of neoplastic diseases. Developed by experts in the RFA field, including notable contributions from MIT-affiliated Prof. Eric R. Cosman, the system builds on decades of research and innovation since the early inventions by Bernard J. Cosman ...
CONTACT SUPPLIER

YSOPIA - Model Yso2 - Develop Christensenella Gut Bacteria

YSOPIA - Model Yso2 - Develop Christensenella Gut Bacteria

by:Verb Biotics   based inBoston, MASSACHUSETTS (USA)
Yso2 is a preclinical program targeting Crohn’s disease. It aims to develop Christensenella gut bacteria as a safe, efficient and groundbreaking oral biotherapy. YSOPIA has identified a lead candidate to relieve Crohn’s disease associated symptoms and slow down disease progression. ...
CONTACT SUPPLIER

Model Metabolics - Adiponectin

Model Metabolics - Adiponectin

by:Boston Heart Diagnostics Corporation   based inFramingham, MASSACHUSETTS (USA)
Adiponectin is a measure of the amount of a hormone produced by fat cells that protects against developing heart disease and diabetes. ...
CONTACT SUPPLIER

Precision Medicine

Precision Medicine

by:Psychē Systems Corporation   based inHopkinton, MASSACHUSETTS (USA)
No two people’s bodies are exactly the same, so it stands to reason that people will react to medicines and treatments in different ways. While medical treatments can have broad, overall positive results, those results become varied when you examine the results in individual people and even in specific populations. That’s where precision medicine comes in. Precision medicine is the ...
CONTACT SUPPLIER

Intellia - Model CRISPR/Cas9 - The Ideal Genome Editing Technology

Intellia - Model CRISPR/Cas9 - The Ideal Genome Editing Technology

by:Intellia Therapeutics, Inc.   based inCambridge, MASSACHUSETTS (USA)
Genome editing is efficient, precise and scalable. CRISPR/Cas9 genome editing can make permanent, precisely targeted changes in patients’ chromosomes and repair the underlying genetic mutation, whereas more traditional gene therapy typically involves introducing a non-permanent copy of a gene into patients’ cells. These attributes of CRISPR/Cas9 provide a significant therapeutic edge ...
CONTACT SUPPLIER

Finch - Model TAK-524 & FIN-525 - Microbiome Therapeutics for Inflammatory Bowel Disease (IBD)

Finch - Model TAK-524 & FIN-525 - Microbiome Therapeutics for Inflammatory Bowel Disease (IBD)

Manufactured by:Finch Therapeutics Group, Inc.   based inSomerville, MASSACHUSETTS (USA)
In collaboration with Takeda Pharmaceuticals, we are developing FIN-524 and FIN-525, orally administered, Targeted Consortia product candidates designed for the treatment of ulcerative colitis (UC) and Crohn’s disease (CD), respectively. UC and CD are the two most common types of IBD, an autoimmune condition that causes inflammation of the gastrointestinal ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT